Keratinocyte and lymphocyte apoptosis: Relation to disease outcome in systemic lupus erythematosus patients with and without cutaneous manifestations

European Journal of Dermatology

Volumn 20, Issue 1, 2010, Pages 35-41

  Salem, Samar Abdallah M ^a   Farouk, Hanan Mohamed ^a   Mostafa, Afaf A ^a   Aly Hassan, Iman M ^a   Osman, Wesam M ^a   Al Shamy, Hebat Allah Ahmed ^a   Assaf, Naglaa Youssef M ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Apoptosis; Lymphocytes; Macrophage function; Skin; Systemic lupus erythematosus

Indexed keywords

ANTIMALARIAL AGENT; NEOPTERIN; PREDNISONE;

ADULT; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; GLOMERULONEPHRITIS; HUMAN; HUMAN TISSUE; KERATINOCYTE; KIDNEY BIOPSY; LYMPHOCYTE; MACROPHAGE FUNCTION; MALE; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; RASH; SKIN BIOPSY; SKIN MANIFESTATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; APOPTOSIS; COMPLEMENT C4; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; LUPUS ERYTHEMATOSUS, CUTANEOUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTES; MALE; MIDDLE AGED; NEOPTERIN; SKIN; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 76749100619     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2010.0812     Document Type: Article

References (32)

1. Hoi AY, Morand EF, Leech M. Is macrophage migration inhibitory factor a therapeutic target in systemic lupus erythematosus? Immunol Cell Biol 2003; 81: 367-73.
2. Rogers NJ, Lees MJ, Gabriel L, et al. A defect in Marco expression contributes to systemic lupus erythematosus development via failure to clear apoptotic cells. J Immunol 2009; 182: 1982-90.
3. Reefman E, Dustelbloem HM, Limburg PC. Fc gamma receptors in the initiation and progression of systemic lupus erythematosus. Immunol Cell Biol 2003; 81: 382-9.
4. Bengtsson AA, Gullstrand B, Truedsson L, Sturfelt G. SLE serum induces classical caspase - dependent apoptosis independent of death receptors. Clin Immunol 2008; 126: 57-66.
5. Baima B, Sticherling M. Apoptosis in different cutaneous manifestations of lupus erythematosus. Br J Dermatol 2001; 144: 958-66.
6. Bijl M, Reefman E, Limburg PC, Kallenberg CGM. Inflammatory clearance of apoptotic cells after UVB challenge. Autoimmunity 2007; 40: 244-8.
7. Dieker JW, Fransen JH, Van Bavel CC, Briand JP, Jocobs CW, Muller S, Berden JH and Van der Vlag J. Apoptosis induced acetylation of histones is pathogenic in systemic lupus erythematosus. Arthritis Rheum 2007; 56: 1921-33.
8. Schiller M, Bekeredjian-Ding I, Heder P, Blank N, Ho AD, Lorenz HM. Autoantigens are translocated into small apoptotic bodies during early stages of apoptosis. Cell Death Differ 2008; 15: 183-91.
9. Jin O, Sun L, Zhou K, et al. Lymphocyte apoptosis and macrophage function: correlation with disease activity in systemic lupus erythematosus. Clin Rheumatol 2005; 24: 107-10.
10. Wirleitner B, Obermoser G, Bock G, Neurauter G and Schennach H. Induction of apoptosis in human body T cells by 7,8 dihydroneopterin: the difference between healthy controls and patients with systemic lupus erythematosus. Clin Immunol 2003; 107: 152-9.
11. Chang MK, Binder CJ, Torzewski M, Witztum JL. C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: phosphatidylcholine of oxidized phospholipids. Proc Natl Acad Sci USA 2002; 99: 13043-8.
12. Berdowska A, Zwirska-Korczala K. Neopterin measurement in clinical diagnosis. J Clin Pharm Ther 2001; 26: 319-29.
13. Speth C, Stock G, Fuchus D, et al. Lass-Florlc and Dierich MP. Inflammation marker 7,8-dihydroneopterin induces apoptosis of neurons and glial cells: a potential contribution to neurodegenerative processes. Immunobiol 2000; 2002: 460-7.
14. Flierman R, Daha MR. The clearance of apoptotic cells by complement. Immunology 2007; 212: 363-70.
15. Teraki Yand Skiohara T. Apoptosis and the skin. Eur J Dermatol 1999; 9: 413-25.
16. Tan EM, Cohen AS, Fries TF and McShone DJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
17. Bombardier C, Goldman DD, Vrowitz MB, Chang CH. Committee on prognosis studies in SLE. Derivation of the SLEDAI: A disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630-40.
18. Pablos JL, Santiago B, Galindo M, Carreiva PE, Ballestin C, Gomez-Reino JJ. Keratinocyte apoptosis and p53 expression in cutaneous lupus and dermatomyositis. J Pathol 1999; 188: 63-8.
19. Reefman E, de Jong MC, Kuiper H, et al. Is disturbed clearance of apoptotic keratinocytes responsible for UVB- induced inflammatory skin lesions in systemic lupus erythematosus? Arthritis Res 2006; 8: R156.
20. Grishman E, Gerber MA, and Churg J. Pattern of renal injury in systemic lupus erytehmatosus: light and immunofluorescence microscopic observations. Am J Kid Dis 1982; 2: 135-41.
21. Austin HA, Boumpas DT, Vanghan EM, Bolow JE. Predicting renal outcomes in severe lupus nephritis: Contributions of clinical and histological data. Kidney Int 1994; 45: 544-50.
22. Knapp RG, Miler MC. Clinical epidemiology and biostatistics. Harwal Publishing Company, 1992.
23. Kuhn A, Herrmann M, Kleber S, et al. Accumulation of apoptotic cells in the epidermis of patients with cutaneous lupus erythematosus after ultraviolet irradiation. Arthritis Rheum 2009; 54: 939-50.
24. Reefman E, Kuiper H, Jonkiman MF, Limburg PC, Kallenberg CG, Bijl M. Skin sensitivity to UVB irradiation in systemic lupus erythematosus is not related to the level of apoptosis induction in keratinocytes. Rheumatology (Oxford) 2006; 45: 538-44.
25. Gaipl US, Munoz LE, Grossmayer G, Lauber K, Franz S, Sarter K, Voll RE, Winkler T, Kuhn A, Kalder J, Kern P, and Herrmann M. Clearance deficiency and systemic lupus erythematosus (SLE). J Autoimmunity 2007; 28: 114-21.
26. Carroll MC. A protective role for innate immunity in systemic lupus erythematosus. Nat Rev Immunol 2004; 4: 825-31.
27. Habib HM, Taher TE, Isenberg DA, Mageed RA. Enhanced propensity of T lymphocytes in patients with systemic lupus erythematosus to apoptosis in the presence of tumour necrosis factor alpha. Scand J Rheumatol 2009; 38: 112-20.
28. Meller S, Winterberg F, Gilliet M, et al. Ultraviolet radiation-induced injury. Chemokines and leukocyte recruitment: an amplification cycle triggering cutaneous lupus erythematosus. Arthritis Rheum 2005; 52: 1504-16.
29. Lauber K, Blumenthal SG, Waibel M, Wesselborg S. Clearance of apoptotic cells: Getting rid of the corpses. Mol Cell 2004; 14: 277-87.
30. Gullstrand B, Martensson U, Sturfelt G, Bengtsson AA, Truedsson L. Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cells. Clin Exp Immunol 2009; 156: 303-11.
31. Tao D, Shangwu L, Qun W. CD226 expression deficiency cause high sensitivity to apoptosis in NK T cells from patients with systemic lupus erythematosus. J Immunol 2005; 174: 1281-90.
32. Bloom RD, O'Connor T, Cizman B. Intrathymic kidney cells delay the onset of lupus nephritis in MRL-Ipr/Ipr mice. Int Immunol 2002; 14: 867-71.